International Clinical Trial: A Single Dose, Randomized, Open-label, Two-way Crossover Bioequivalence Study of Generic Fixed-dose Combination of Sitagliptin and Metformin Hydrochloride 50/1000 mg Film-coated Tablets and Reference Product (JANUMET (50 MG/1000 MG)) in Healthy Thai Volunteers under Fed Conditions

Geneva, April 27 -- International Clinical Trials Registry received information related to the study (TCTR20260405006) titled 'A Single Dose, Randomized, Open-label, Two-way Crossover Bioequivalence Study of Generic Fixed-dose Combination of Sitagliptin and Metformin Hydrochloride 50/1000 mg Film-coated Tablets and Reference Product (JANUMET (50 MG/1000 MG)) in Healthy Thai Volunteers under Fed Conditions' on April 5.

Study Type: Interventional

Study Design: Randomized

Primary Sponsor: International Bio Service Co., Ltd.

Condition: Bioequivalence Study Healthy Thai Volunteers Sitagliptin / Metformin Hydrochloride Tablets 50 mg / 1000 mg Bioequivalence Study Healthy Thai Volunteers Sitagliptin / Metformin Hydrochloride Tablets 50 mg...